The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2024

Filed:

Mar. 31, 2023
Applicants:

Abcellera Biologics Inc., Vancouver, CA;

The United States of America, As Represented BY the Secretary, Department of Health and Human Svcs., Bethesda, MD (US);

Inventors:

Kathryn Westendorf, Vancouver, CA;

Stefanie Zentelis, Vancouver, CA;

Krithika Muthuraman, Toronto, CA;

Kevin Jepson, Vancouver, CA;

Ester Falconer, North Vancouver, CA;

John Mascola, Bethesda, MD (US);

Barney Graham, Bethesda, MD (US);

Kizzmekia Corbett, Bethesda, MD (US);

Julie Ledgerwood, Bethesda, MD (US);

Lingshu Wang, Bethesda, MD (US);

Olubukola Abiona, Bethesda, MD (US);

Wei Shi, Bethesda, MD (US);

Wing-pui Kong, Bethesda, MD (US);

Yi Zhang, Bethesda, MD (US);

Bryan Edward Jones, San Diego, CA (US);

Denisa Foster, San Diego, CA (US);

Julian Davies, La Jolla, CA (US);

Qing Chai, San Diego, CA (US);

Christopher Carl Frye, Bargersville, IN (US);

Ganapathy Gopalrathnam, Fishers, IN (US);

Jörg Hendle, San Diego, CA (US);

John Michael Sauder, Carlsbad, CA (US);

Jeffrey Streetman Boyles, Indianapolis, IN (US);

Anna Pustilnik, San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 11/00 (2006.01); A61K 39/00 (2006.01); A61K 39/215 (2006.01); A61K 47/02 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/68 (2017.01); A61P 31/14 (2006.01); C07K 16/10 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6801 (2017.08); A61K 39/215 (2013.01); A61K 47/02 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/68 (2017.08); A61K 47/6841 (2017.08); A61P 11/00 (2018.01); A61P 31/14 (2018.01); C07K 16/1003 (2023.08); G01N 33/5091 (2013.01); G01N 33/56983 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/165 (2013.01); G01N 2800/26 (2013.01);
Abstract

Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.


Find Patent Forward Citations

Loading…